🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety, tolerability and clini...
Status
Completed
Location
Multiple Locations
Start Date
2016-01-27
Trial ID
NCT02622074
Treatments Being Tested
The study will evaluate the clinical activity of PD-(L)1 Checkpoint Inhibit...
Status
Terminated
Location
The University of Arizona Cancer Center
Start Date
2018-09-11
Trial ID
NCT03606174
Treatments Being Tested
The Primary Objective was: -To determine the antitumor activity of SAR4442...
Status
Terminated
Location
Thomas Jefferson University Hospital Site Number : 8400009
Start Date
2021-09-23
Trial ID
NCT04914897
Treatments Being Tested
The purpose of this investigator-initiated, multicenter phase II trial is t...
Status
Recruiting
Location
Aalborg University Hospital
Start Date
2023-02-01
Trial ID
NCT05732389
Treatments Being Tested
This is a study of single-agent pembrolizumab (MK-3475) in participants wit...
Status
Completed
Location
Multiple Locations
Start Date
2014-10-24
Trial ID
NCT02255097
Treatments Being Tested
The purpose of this study was to determine the antitumor activity of enfort...
Status
Completed
Location
Site CN86001
Start Date
2021-07-22
Trial ID
NCT04995419
Treatments Being Tested
The purpose of this study is to assess the safety and tolerability and to e...
Status
Active Not Recruiting
Location
Sanford Cancer Center ( Site 0005)
Start Date
2022-06-16
Trial ID
NCT05382325
Treatments Being Tested
This early phase trial will address the following key objectives: 1. Compl...
Status
Enrolling By Invitation
Location
Foothills Medical Centre
Start Date
2024-12-01
Trial ID
NCT05967728
Treatments Being Tested
The purpose of this study is to determine the efficacy and safety of pembro...
Status
Completed
Location
UCLA Medical Center ( Site 0273)
Start Date
2017-04-05
Trial ID
NCT03040999
This study will evaluate the safety and efficacy of pembrolizumab (MK-3475)...
Status
Completed
Location
Banner MD Anderson Cancer Center ( Site 0026)
Start Date
2019-05-28
Trial ID
NCT03867084
Treatments Being Tested